(Q34990631)

5 August 2017

1 reference

title

Lipoprotein abnormalities related to women's health (English)

1 reference

5 August 2017

1 reference

Vera Bittner

1

1 reference

PubMed ID

12419484

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Cardiology

5 August 2017

1 reference

5 August 2017

90

1 reference

5 August 2017

77i-84i

1 reference

5 August 2017

8A

1 reference

Why do women live longer than men? Biologic differences that influence longevity

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Lifetime risk of developing coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Distribution and correlates of high-density lipoprotein subclasses among children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Sex hormones and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Epidemiology of oral contraceptives and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Serum lipids in young women before, during, and after pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Some atherogenic concomitants of menopause: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Perimenopausal increase in serum cholesterol: a 10-year longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Longitudinal study of risk factors for coronary heart disease across the menopausal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Menopause and risk factors for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Menopause is associated with reduced protection from postprandial lipemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Fluctuations of lipid and lipoprotein levels in hyperlipidemic postmenopausal women receiving hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of long-term transdermal administration of estradiol on serum lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: the postmenopausal estrogen/progestins interventions (PEPI) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Estrogens, lipids and cardiovascular disease: no easy answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Sex differences in HAART-associated dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Cholesterol and mortality. 30 years of follow-up from the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

High-density lipoprotein--the clinical implications of recent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Low density lipoprotein particle size and risk of early-onset myocardial infarction in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

LDL size and risk of coronary heart disease in elderly men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Range of serum cholesterol values in the population developing coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

Plasma triglyceride and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902637-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02637-1

1 reference

5 August 2017

1 reference

PubMed ID

12419484